RGNX

REGENXBIO Inc
23.75
-0.31 (-1.29%)

REGENXBIO Inc. (RGNX) Fundamentals

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).
SHARE INFORMATION
Market Cap$ 1,041,644,762
Shares Outstanding43,293,631
Float28,426,789
Percent Float65.66%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 470,347,000
Latest Fiscal EPS$ 2.91
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions421
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months1,326,738
Institutional Holdings Percent141.8%
Institutional Sold Previous 3 Months4,350,334
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months-
Insider Holdings Percent1.3
Insider Sold Previous 3 Months-
Insider Shares Owned568,378
TRADING INFO
52 Week High$ 35.73
52 Week Low$ 18.69
52 Week High Change$ -3.30
21 Day Moving Average$ 23.1219
21 Day Extended Moving Average$ 23.1279
50 Day Moving Average$ 22.915
50 Day Extended Moving Average$ 23.095
200 Day Moving Average$ 25.1246
200 Day Extended Moving Average$ 25.39
10 Day Average Volume383,674
20 Day Average Volume339,212
30 Day Average Volume357,873
50 Day Average Volume354,799
Alpha0.001606
Beta1.0471
Standard Deviation0.159416
R20.125882
7 Day Price Change$ 1.06
7 Day Percent Change4.61%
21 Day Price Change$ -0.32
21 Day Percent Change-1.31%
30 Day Price Change$ 1.38
30 Day Percent Change6.08%
Month to Date Price Change$ 0.85
Month to Date Percent Change3.66%
Quarter to Date Price Change$ 1.38
Quarter to Date Percent Change6.08%
180 Day Price Change$ -7.75
180 Day Percent Change-24.36%
200 Day Price Change$ -7.53
200 Day Percent Change-23.84%
Year to Date Price Change$ 1.38
Year to Date Percent Change6.08%

REGENXBIO Inc. (RGNX) Key Ratios

PROFITABILITY
EBIT Margin23.4%
EBITDA Margin25.8%
Pre-Tax Profit Margin-28.7%
Profit Margin Count10.39%
Gross Margin86.5%
Profit Margin TOT10.39%
INCOME STATEMENTS
Revenue$ 81,379,000
Revenue Per Share$ 1.8797
Revenue (3 Years)$ 59.17
Revenue (5 Years)$ 60.64
FINANCIAL STRENGTH
Price to Tangible Book1.80
Total Debt To Equity0.20
Int Coverage4.40
Current Ratio3.50
Leverage Ratio1.50
Quick Ratio3.40
Long Term Debt To Capital0.13
VALUATION MEASURES
PE Ratio13.60
Enterprise Value$ 721,964,519
Price to Sales12.7999
Price to Free Cash-5.30
PE High Last 5 Years22.30
Price To Book1.80
Price To Cash Flow6.00
PE Low Last 5 Years-9.40
Price to Tangible Book1.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.80
Invoice Turnover0.00
Assets Turnover0.00
Return Assets8.74
Return on Equity14.36
Return on Capital15.84

REGENXBIO Inc. (RGNX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEOKenneth T. Mills
Emplyoees372
Last AuditUQ
CIK0001590877
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address9804 Medical Center Drive
Suite 210
Rockville, MD 20850
Websitehttps://www.regenxbio.com
Facsimile-
Telephone+1 240 552-8181
Emailttruehart@regenxbio.com


Your Recent History
NASDAQ
RGNX
REGENXBIO
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.